A study into the long-term health impacts of coronavirus, led by experts from the University of Leicester, Imperial College ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a good thing? By Kristen V. Brown As Kimberly Crisp approached middle age, ...

CLEVELAND, Ohio — Pancreatic cancer stands apart from many common cancers for a troubling reason: There is no standard screening test to catch the disease early, when treatment is most effective. That ...

Finding the perfect early screening test for cancer remains a persistent challenge for the health industry. But new findings suggest that blood tests still being assessed are showing promising results ...

Hot off the trail of National Breast Cancer Month in October, one company is trying to ease the detection of the disease that has been projected to impact at least 316,950 women across the country in ...

Octave's collaboration with Quest Diagnostics will expand access to its multiple sclerosis disease activity test in the U.S. The MSDA blood test helps monitor disease activity for better treatment ...

There’s new progress in the battle against Alzheimer’s disease. About 1 in 9 US seniors has Alzheimer’s, the most common form of dementia, which slowly impairs memory, thinking skills and the ability ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...

The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny particles known as exosomes—is becoming increasingly realistic. Scientists ...

Progress in cutting the global toll of cancer remains painfully slow, but a new blood test has sparked unusual levels of hope. Researchers say it could one day make routine screening far more ...

John Ferguson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...